These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 9317166)
1. HLA-Cw3 expression on porcine endothelial cells protects against xenogeneic cytotoxicity mediated by a subset of human NK cells. Seebach JD; Comrack C; Germana S; LeGuern C; Sachs DH; DerSimonian H J Immunol; 1997 Oct; 159(7):3655-61. PubMed ID: 9317166 [TBL] [Abstract][Full Text] [Related]
2. Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicity. Lilienfeld BG; Crew MD; Forte P; Baumann BC; Seebach JD Xenotransplantation; 2007 Mar; 14(2):126-34. PubMed ID: 17381687 [TBL] [Abstract][Full Text] [Related]
3. HLA-E and HLA-G expression on porcine endothelial cells inhibit xenoreactive human NK cells through CD94/NKG2-dependent and -independent pathways. Sasaki H; Xu XC; Mohanakumar T J Immunol; 1999 Dec; 163(11):6301-5. PubMed ID: 10570324 [TBL] [Abstract][Full Text] [Related]
4. A study of HLA-G1 protection of porcine endothelial cells against human NK cell cytotoxicity. Wang SS; Han JY; Wu XW; Cao RH; Qi HG; Xia ZX; Chen D; Gong FL; Chen S Transplant Proc; 2004 Oct; 36(8):2473-4. PubMed ID: 15561285 [TBL] [Abstract][Full Text] [Related]
5. A study of soluble HLA-G1 protecting porcine endothelial cells against human natural killer cell-mediated cytotoxicity. Zeng MH; Fang CY; Wang SS; Zhu M; Xie L; Li R; Wang L; Wu XW; Chen S Transplant Proc; 2006 Dec; 38(10):3312-4. PubMed ID: 17175258 [TBL] [Abstract][Full Text] [Related]
6. An HLA-E single chain trimer inhibits human NK cell reactivity towards porcine cells. Crew MD; Cannon MJ; Phanavanh B; Garcia-Borges CN Mol Immunol; 2005 Jun; 42(10):1205-14. PubMed ID: 15829309 [TBL] [Abstract][Full Text] [Related]
7. CD8-interaction mutant HLA-Cw3 molecules protect porcine cells from human natural killer cell-mediated antibody-dependent cellular cytotoxicity without stimulating cytotoxic T lymphocytes. Sharland A; Lee JH; Saidman S; Waneck GL Transplantation; 2003 Dec; 76(11):1615-22. PubMed ID: 14702534 [TBL] [Abstract][Full Text] [Related]
8. The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3 zeta chain, Fc epsilon RI gamma chain and the p56lck kinase. Bottino C; Vitale M; Olcese L; Sivori S; Morelli L; Augugliaro R; Ciccone E; Moretta L; Moretta A Eur J Immunol; 1994 Oct; 24(10):2527-34. PubMed ID: 7523145 [TBL] [Abstract][Full Text] [Related]
10. Self class I molecules protect normal cells from lysis mediated by autologous natural killer cells. Ciccone E; Pende D; Vitale M; Nanni L; Di Donato C; Bottino C; Morelli L; Viale O; Amoroso A; Moretta A Eur J Immunol; 1994 Apr; 24(4):1003-6. PubMed ID: 8149950 [TBL] [Abstract][Full Text] [Related]
11. HLA-Cw4 expression on porcine endothelial cells reduces cytotoxicity and adhesion mediated by CD158a+ human NK cells. Forte P; Baumann BC; Schneider MK; Seebach JD Xenotransplantation; 2009; 16(1):19-26. PubMed ID: 19243557 [TBL] [Abstract][Full Text] [Related]
12. MHC class I expression on tumor targets inhibits natural killer cell-mediated cytotoxicity without interfering with target recognition. Kaufman DS; Schoon RA; Leibson PJ J Immunol; 1993 Feb; 150(4):1429-36. PubMed ID: 8432986 [TBL] [Abstract][Full Text] [Related]
13. Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2). Ciccone E; Pende D; Viale O; Than A; Di Donato C; Orengo AM; Biassoni R; Verdiani S; Amoroso A; Moretta A J Exp Med; 1992 Oct; 176(4):963-71. PubMed ID: 1328466 [TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of human and mouse natural killer tumor recognition using retroviral antisense in primary natural killer cells: involvement with MHC class I killer cell inhibitory receptors. Ortaldo JR; Mason AT; Mason LH; Winkler-Pickett RT; Gosselin P; Anderson SK J Immunol; 1997 Feb; 158(3):1262-7. PubMed ID: 9013968 [TBL] [Abstract][Full Text] [Related]
15. Human NK cells can lyse porcine endothelial cells independent of their expression of Galalpha(1,3)-Gal and killing is enhanced by activation of either effector or target cells. Horvath-Arcidiacono JA; Porter CM; Bloom ET Xenotransplantation; 2006 Jul; 13(4):318-27. PubMed ID: 16768725 [TBL] [Abstract][Full Text] [Related]
16. Natural killing of xenogeneic cells mediated by the mouse Ly-49D receptor. Nakamura MC; Naper C; Niemi EC; Spusta SC; Rolstad B; Butcher GW; Seaman WE; Ryan JC J Immunol; 1999 Nov; 163(9):4694-700. PubMed ID: 10528166 [TBL] [Abstract][Full Text] [Related]
17. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL. Bakker AB; Phillips JH; Figdor CG; Lanier LL J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119 [TBL] [Abstract][Full Text] [Related]
18. Human Fas-ligand expression on porcine endothelial cells does not protect against xenogeneic natural killer cytotoxicity. Matter-Reissmann UB; Sonntag KC; Gilli UO; Leguern C; Schneider MK; Seebach JD Xenotransplantation; 2004 Jan; 11(1):43-52. PubMed ID: 14962292 [TBL] [Abstract][Full Text] [Related]
19. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484 [TBL] [Abstract][Full Text] [Related]
20. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. Moretta A; Vitale M; Bottino C; Orengo AM; Morelli L; Augugliaro R; Barbaresi M; Ciccone E; Moretta L J Exp Med; 1993 Aug; 178(2):597-604. PubMed ID: 8340759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]